SCYNEXIS discusses asset acquisition in corporate update call

SCYNEXIS INC

Conference call held on March 31, 2026 covering an asset acquisition transaction.
Slide presentation filed as Exhibit 99.1; no financial terms disclosed in this 8-K.
Company's deck highlights focus on severe rare disease solutions.
No specific revenue, earnings, or closing timeline provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.